NCT00424827View on ClinicalTrials.gov

A Trial of Chemo & Radiation Therapy for Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Pancreatic Cancer
Interventions
DRUG

Gemcitabine/Fluorouracil with External Beam Radiation

This protocol will assess the antitumor activity of gemcitabine (200 mg/m2 per week) and cetuximab (400mg/m2 loading dose followed by 250 mg/m2 weekly) when given with continuous infusion 5-FU (200 mg/m2/day/M-F) and daily concurrent external beam radiation therapy (50.4 Gy) in patients with non-metastatic, locally advanced pancreatic carcinoma.

All Listed Sponsors
lead

University of Massachusetts, Worcester

OTHER

NCT00424827 - A Trial of Chemo & Radiation Therapy for Pancreatic Cancer | Biotech Hunter | Biotech Hunter